Cancer and cardiovascular disease (CVD) are the two biggest killers worldwide. Specific
treatments have been developed for the two diseases. However, mutual therapeutic targets …

Background The combination of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) with
endocrine therapy (ET) is the standard of care for patients with hormone receptor …

The issue highlights the need to bridge racial and ethnic disparities in cancer research to
promote equitable healthcare outcomes. Our knowledge of unique risk factors and disease …

Peripheral neuropathy (PN) is a multifaceted disorder characterised by peripheral nerve
damage, manifesting in symptoms like pain, weakness, and autonomic dysfunction. This …

Introduction: Adolescents and young adults (AYA) are a unique subgroup of patients who
experience cancer at the interface between pediatric and adult oncology services. Central …

Background Iatrogenesis is an inevitable global threat to healthcare that drastically
increases morbidity and mortality. Cancer is a fatal pathological condition that affects people …

Hepatocellular carcinoma (HCC) is a progressed form of advanced liver cancer and is one
of the major causes of global cancer burden. The primary causes for high HCC mortality is …

Treosulfan has shown promise in allogeneic hematopoietic cell transplantation (HCT) for its
myeloablative properties and low toxicity. In this single-center retrospective propensity score …

Photodynamic therapy (PDT) is an approved minimum-invasive therapeutic approach
authorized for the clinical treatment of various types of cancer and antibiotic-resistant …

Purpose: The study aims to investigate racial disparities in fall-related injuries among Black
and White breast cancer survivors who received chemotherapy, focusing on the risks …